Long‐term Ketoconazole Treatment of Chronic Acral Dermatophyte Infections

Abstract: Ketoconazole 200–400 mg was given once daily for a maximum period of 12 months to 31 patients with chronic (mean duration, 12 years) dermatophyte infections of the hands and/or feet. Griseofulvin had previously been withdrawn due to intolerance or lack of effect. All skin and nail infections improved clinically. Fifty percent of the patients with skin infections and 26% of those with nail infections became clinically clear and culture‐negative. Six months later, relapses had occurred in 8 of 12 patients (67%) with cleared skin lesions, and in 2 of 5 (40%) with cleared nail infections. Ketoconazole was discontinued in one patient due to headache and in another due to asymptomatic transient elevation of hepatic laboratory tests. Ketoconazole is an alternative when a replacement for griseofulvin is required, provided the degree of disability justifies the risk of drug toxicity.

[1]  P. Janssen,et al.  Hepatic reactions during ketoconazole treatment. , 1983, The American journal of medicine.

[2]  E. Nieschlag,et al.  KETOCONAZOLE-INDUCED DROP IN SERUM AND SALIVA TESTOSTERONE , 1982, The Lancet.

[3]  Y. Clayton,et al.  Treatment of chronic dermatophyte infections. The use of ketoconazole in griseofulvin treatment failures , 1982, Clinical and experimental dermatology.

[4]  H. Blank.  Commentary: Treatment of Dermatomycoses With Griseofulvin , 1982 .

[5]  D. Stevens,et al.  Ketoconazole blocks adrenal steroid synthesis. , 1982, Annals of internal medicine.

[6]  A. Ahmed,et al.  Immunology of human dermatophyte infections. , 1982, Archives of dermatology.

[7]  L. Ranek,et al.  Hepatic dysfunction and ketoconazole therapy. , 1982, Annals of internal medicine.

[8]  F. W. Cox,et al.  Oral ketoconazole for dermatophyte infections. , 1982, Journal of the American Academy of Dermatology.

[9]  J. Hanifin,et al.  Ketoconazole in griseofulvin-resistant dermatophytosis. , 1982, Journal of the American Academy of Dermatology.

[10]  G. Laurberg.  Ketoconazole in Trichophyton rubrum. , 1982, Acta dermato-venereologica.

[11]  J. Graybill,et al.  Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid , 1981, Antimicrobial Agents and Chemotherapy.

[12]  J. G. Simpson,et al.  Oral ketoconazole. An effective and safe treatment for dermatophytosis. , 1981, Archives of dermatology.

[13]  M. Borgers.  Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. , 1980, Reviews of infectious diseases.

[14]  T. Kaaman.  The clinical significance of cutaneous reactions to trichophytin in dermatophytosis. , 1978, Acta dermato-venereologica.

[15]  J. Wasserman,et al.  An evaluation of delayed hypersensitivity in guinea pigs to various trichophytin preparations. , 1976, Acta dermato-venereologica.

[16]  D. Anderson.  GRISEOFULVIN: BIOLOGY AND CLINICAL USEFULNESS. A REVIEW. , 1965, Annals of allergy.